Literature DB >> 28920328

Incidence and mortality of breast cancer in China, 2008.

Wan-Qing Chen1, Rong-Shou Zheng1, Hong-Mei Zeng1, Si-Wei Zhang1, Guang-Lin Li2, Liang-You Wu2, Jie He1.   

Abstract

BACKGROUND: Female breast cancer incidence and mortality data for the duration of 2008, in China, retrieved from the National Central Cancer Registry, was analyzed.
METHODS: In 2008, there were 56 registries that submitted cancer registration data. Based on the criteria of data quality, a total of 41 registries' data met the requirement and were accepted for analysis. The incidence and mortality rates of breast cancer in females were calculated, including age specific rates, age-standardized rates, proportions, and cumulative rates, stratified by areas (urban/rural).
RESULTS: The number of cases included from 41 registries was 66 138 784, with 32 798 187 of these cases found in women (25 898 251 in urban areas and 6 899 936 in rural areas). There were 15 625 new cases reported and 3414 deaths of women with breast cancer, resulting in a mortality to incidence ratio of 0.22. The morphological verified rate was 91.96%, and 0.43% of cases were identified by death certificate only. The crude cancer incidence rate in all areas was 47.64/100 000, and the Age-Standardized Incidence Rates by Chinese standard population, (ASIRC) and World standard population (ASIRW) were 25.26/100 000 and 31.71/100 000, respectively. The cumulative incidence rate (0-74 years old) was 3.44%. Both crude and adjusted incidence rates in urban areas were much higher than those in rural areas. The crude cancer mortality was 10.41/100 000, and the Age-Standardized Mortality Rates by Chinese standard population (ASMRC) and by World population (ASMRW) were 4.90/100 000 and 6.48/100 000, respectively. The cumulative mortality rate (0-74 years old) was 0.071%. Age-adjusted mortality rates in urban areas were also higher than in rural areas. Age specific incidence rates peaked in age group 50-54 in all areas (108.27/100 000) and in urban areas (119.68/100 000). It reached the peak in the 55-59 age group for rural women. Age specific mortalities rose with the increase of age for both women in urban and rural areas, with mortality rates of 76.16/100 000 and 23.73/100 000 in age groups of 85 and above, respectively.
CONCLUSIONS: Breast cancer is the most common cancer diagnosed in Chinese women. Preventative measures, such as health education and screening, are needed in the general population, but especially for those in the high-risk group found in urban areas.
© 2012 Tianjin Lung Cancer Institute and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Breast cancer; China; cancer registry; incidence; mortality

Year:  2013        PMID: 28920328     DOI: 10.1111/j.1759-7714.2012.00165.x

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN: 1759-7706            Impact factor:   3.500


  5 in total

1.  Development of a risk assessment tool for projecting individualized probabilities of developing breast cancer for Chinese women.

Authors:  Yuan Wang; Ying Gao; Munkhzul Battsend; Kexin Chen; Wenli Lu; Yaogang Wang
Journal:  Tumour Biol       Date:  2014-08-02

2.  Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer.

Authors:  Weihong Liu; Ignacio García De La Torre; María Cristina Gutiérrez-Rivera; Bo Wang; Yuan Liu; Liping Dai; Wei Qian; Jian-Ying Zhang
Journal:  Tumour Biol       Date:  2014-10-30

3.  The co-expression of telomerase and ALT pathway in human breast cancer tissues.

Authors:  Bin Xu; Min Peng; Qibin Song
Journal:  Tumour Biol       Date:  2013-12-28

4.  Urban-rural disparity of breast cancer and socioeconomic risk factors in China.

Authors:  Xufeng Fei; Jiaping Wu; Zhe Kong; George Christakos
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

5.  Prevalence of BRCA1 and BRCA2 Germline Mutations in Breast Cancer Women of Multiple Ethnic Region in Northwest China.

Authors:  Jianghua Ou; Tao Wu; Rolf Sijmons; Duo Ni; Wenting Xu; Halmurat Upur
Journal:  J Breast Cancer       Date:  2013-03-31       Impact factor: 3.588

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.